Phreesia just hit profitability—and got punished for it. With insiders loading up and institutions fully committed, is this a classic overreaction or a value trap? Let’s decode the dip.

Read entire article

SoFi just delivered its first billion-dollar quarter, record member growth, and a fresh insider buy from CEO Anthony Noto. The fintech story is evolving from speculative startup to profitable platform — but valuation and skepticism remain. Here’s the FUNanc1al breakdown of the opportunity.

Read entire article

Aurora Innovation just got a $1M vote of confidence from its CEO — and major institutions like Uber, T. Rowe Price, and Morgan Stanley are all aboard. But with high cash burn, big ambitions, and a stock under $5, is this the moment to buckle up or bail out? 🚚💡🤖

Read entire article

Eli Lilly insiders are opening their wallets after the company crushed Q2 2025 — revenue up 38%, EPS up 92%, and blockbuster drugs Zepbound and Mounjaro fueling a raised guidance. Institutions are all-in, the pipeline is buzzing, but the valuation is sky-high. Is LLY worth chasing at $639, or is patience the better prescription?

Read entire article

Robinhood’s got a new backer — and it’s no amateur. Christopher Payne (ex-DoorDash, Tinder, eBay) just went all in with a bold $2M+ insider buy. Add in huge crypto growth, a string of acquisitions, and global ambitions… and suddenly Robinhood doesn’t just look ready — it looks legendary. Is $HOOD still a buy? Let’s break it down.

Read entire article

Tesla's Q1 numbers stumbled, but billionaires are buying and energy growth is sizzling. 🌋 Is TSLA ready for a rerating, or just revving its engines? We dissect the Muskian mayhem — with laughs and icons, of course. 🚗⚡

Read entire article